Exquiron Biotech offers early stage drug discovery services
based on assay development, high throughput screening, hit finding and characterization. Exquiron was founded in 2013. Exquiron 's headquarters is located in Reinach, Basel-Country, CH 4153.... Exquiron 's Co-Founder & CEO, Stephan Fasler, currently has an approval
rating of 68%. Exquiron 's primary competitors are Domainex, Evotec & DiscoverX.
There have been no acquisitions found related to Exquiron
Funding data cannot be found related to Exquiron
Recent investment data cannot be found related to Exquiron